{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:43:20Z","timestamp":1785807800742,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Intratympanic (IT) drug delivery receives attention due to its effectivity in treatment for Meni\u00e8re\u2019s disease (MD). Due to the release of the consensuses and new evidence on IT drug delivery for MD have been published, the review with a view to supplementing the details of IT treatment of MD is indispensable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The literatures on IT injection for MD treatment over the last two decades are retrieved, International consensus (ICON) on treatment of Meni\u00e8re\u2019s disease (2018), Clinical Practice Guideline (2020) and European Position statement on Diagnosis and Treatment of Meniere\u2019s Disease (2018) are taken into account for reference, and follow advice from experts from Europe, USA and China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Experts agree on the following: (1) The effectiveness of IT methylprednisolone (ITM) on vertigo control seems to be somewhat better than that of IT dexamethasone (ITD), and ITM can restore hearing in some cases. (2) Due to the ototoxicity of aminoglycosides, the application of intratympanic gentamicin (ITG) in MD patients with good hearing is conservative. However, some studies suggest that ITG with low doses has no significant effect on hearing, which needs to be further proved by clinical studies with high levels of evidence. (3) Currently, generally accepted treatment endpoint of ITG is no vertigo attack in a 12-month period or a vestibular loss in objective tests in the affected ear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>More studies with high level of evidence are needed to evaluate the drug type, efficacy, and therapeutic endpoint of IT therapy for MD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00405-022-07374-y","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T04:26:27Z","timestamp":1650947187000},"page":"3795-3799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Consensus on intratympanic drug delivery for Meni\u00e8re\u2019s disease"],"prefix":"10.1007","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0301-5809","authenticated-orcid":false,"given":"Shuna","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmari","family":"Pyykk\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoli","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"issue":"1","key":"7374_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/VES-150549","volume":"25","author":"JA Lopez-Escamez","year":"2015","unstructured":"Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandala M et al (2015) Diagnostic criteria for Meniere\u2019s disease. J Vestib Res 25(1):1\u20137","journal-title":"J Vestib Res"},{"key":"7374_CR2","doi-asserted-by":"publisher","first-page":"16028","DOI":"10.1038\/nrdp.2016.28","volume":"2","author":"T Nakashima","year":"2016","unstructured":"Nakashima T, Pyykko I, Arroll MA, Casselbrant ML, Foster CA, Manzoor NF et al (2016) Meniere\u2019s disease. Nat Rev Dis Primers 2:16028","journal-title":"Nat Rev Dis Primers"},{"issue":"9636","key":"7374_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(08)61161-7","volume":"372","author":"H Sajjadi","year":"2008","unstructured":"Sajjadi H, Paparella MM (2008) Meniere\u2019s disease. Lancet 372(9636):406\u2013414","journal-title":"Lancet"},{"issue":"6","key":"7374_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/archotol.1944.00680010542012","volume":"39","author":"T Bc","year":"1944","unstructured":"Bc T (1944) Injection of the tympanum for chronic conductive deafness and associated tinnitus aurium: a preliminary report on the use of ethylmorphine hydrochloride. Arch Otolaryngol 39(6):523\u2013526","journal-title":"Arch Otolaryngol"},{"issue":"1S","key":"7374_CR5","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.anorl.2017.12.006","volume":"135","author":"J Nevoux","year":"2018","unstructured":"Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V (2018) International consensus (ICON) on treatment of Meniere\u2019s disease. Eur Ann Otorhinolaryngol Head Neck Dis 135(1S):S29\u2013S32","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"2","key":"7374_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.5152\/iao.2018.140818","volume":"14","author":"J Magnan","year":"2018","unstructured":"Magnan J, Ozgirgin ON, Trabalzini F, Lacour M, Escamez AL, Magnusson M et al (2018) European position statement on diagnosis, and treatment of Meniere\u2019s disease. J Int Adv Otol 14(2):317\u2013321","journal-title":"J Int Adv Otol"},{"key":"7374_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599820909438","volume":"162","author":"GJ Basura","year":"2020","unstructured":"Basura GJ, Adams ME, Monfared A, Schwartz SR, Antonelli PJ, Burkard R et al (2020) Clinical practice guideline: Meniere\u2019s disease. Otolaryngol Head Neck Surg 162:S1\u2013S55","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"7374_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/coa.13350","volume":"44","author":"Z Cao","year":"2019","unstructured":"Cao Z, Yue F, Huang W, Rajenderkumar D, Zhao F (2019) Different medications for the treatment of Meniere\u2019s disease by intratympanic injection: a systematic review and network meta-analysis. Clin Otolaryngol 44(4):619\u2013627","journal-title":"Clin Otolaryngol"},{"issue":"95","key":"7374_CR9","first-page":"341","volume":"29","author":"E Masoumi","year":"2017","unstructured":"Masoumi E, Dabiri S, Khorsandi Ashtiani MT, Erfanian R, Sohrabpour S, Yazdani N et al (2017) Methylprednisolone versus dexamethasone for control of vertigo in patients with definite Meniere\u2019s disease. Iran J Otorhinolaryngol 29(95):341\u2013346","journal-title":"Iran J Otorhinolaryngol"},{"issue":"10061","key":"7374_CR10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/S0140-6736(16)31461-1","volume":"388","author":"M Patel","year":"2016","unstructured":"Patel M, Agarwal K, Arshad Q, Hariri M, Rea P, Seemungal BM et al (2016) Intratympanic methylprednisolone versus gentamicin in patients with unilateral Meniere\u2019s disease: a randomised, double-blind, comparative effectiveness trial. Lancet 388(10061):2753\u20132762","journal-title":"Lancet"},{"key":"7374_CR11","doi-asserted-by":"crossref","unstructured":"Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg. 2005;133(2):285\u2013294.","DOI":"10.1016\/j.otohns.2005.05.010"},{"issue":"1","key":"7374_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/lary.27392","volume":"129","author":"JG Naples","year":"2019","unstructured":"Naples JG, Henry L, Brant JA, Eliades SJ, Ruckenstein MJ (2019) Intratympanic therapies in meniere disease: evaluation of outcomes and early vertigo control. Laryngoscope 129(1):216\u2013221","journal-title":"Laryngoscope"},{"issue":"3","key":"7374_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.amjoto.2015.12.007","volume":"37","author":"S Albu","year":"2016","unstructured":"Albu S, Nagy A, Doros C, Marceanu L, Cozma S, Musat G et al (2016) Treatment of Meniere\u2019s disease with intratympanic dexamethazone plus high dosage of betahistine. Am J Otolaryngol 37(3):225\u2013230","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"7374_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/0194599811429432","volume":"146","author":"AP Casani","year":"2012","unstructured":"Casani AP, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I (2012) Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 146(3):430\u2013437","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"7374_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1067\/mhn.2001.119485","volume":"125","author":"L Sennaroglu","year":"2001","unstructured":"Sennaroglu L, Sennaroglu G, Gursel B, Dini FM (2001) Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere\u2019s disease. Otolaryngol Head Neck Surg 125(5):537\u2013543","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"7374_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/MAO.0000000000002108","volume":"40","author":"JP Harcourt","year":"2019","unstructured":"Harcourt JP, Lambert A, Wong PY, Patel M, Agarwal K, Golding JF et al (2019) Long-term follow-up of intratympanic methylprednisolone versus gentamicin in patients with unilateral Meniere\u2019s disease. Otol Neurotol 40(4):491\u2013496","journal-title":"Otol Neurotol"},{"issue":"3","key":"7374_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1017\/S0022215115000171","volume":"129","author":"W She","year":"2015","unstructured":"She W, Lv L, Du X, Li H, Dai Y, Lu L et al (2015) Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Meniere\u2019s disease. J Laryngol Otol 129(3):232\u2013237","journal-title":"J Laryngol Otol"},{"issue":"4","key":"7374_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0194599812472882","volume":"148","author":"N Gabra","year":"2013","unstructured":"Gabra N, Saliba I (2013) The effect of intratympanic methylprednisolone and gentamicin injection on Meniere\u2019s disease. Otolaryngol Head Neck Surg 148(4):642\u2013647","journal-title":"Otolaryngol Head Neck Surg"},{"key":"7374_CR19","doi-asserted-by":"crossref","unstructured":"Nyberg S, Abbott NJ, Shi X, Steyger PS, Dabdoub A. Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier. Sci Transl Med. 2019;11(482).","DOI":"10.1126\/scitranslmed.aao0935"},{"key":"7374_CR20","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2147\/JMDH.S313968","volume":"14","author":"A Tewabe","year":"2021","unstructured":"Tewabe A, Abate A, Tamrie M, Seyfu A, Abdela SE (2021) Targeted drug delivery\u2014from magic bullet to nanomedicine: principles, challenges, and future perspectives. J Multidiscip Healthc 14:1711\u20131724","journal-title":"J Multidiscip Healthc"},{"issue":"8","key":"7374_CR21","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1097\/MAO.0b013e3182908b28","volume":"34","author":"J Paradis","year":"2013","unstructured":"Paradis J, Hu A, Parnes LS (2013) Endolymphatic sac surgery versus intratympanic gentamicin for the treatment of intractable Meniere\u2019s disease: a retrospective review with survey. Otol Neurotol 34(8):1434\u20131437","journal-title":"Otol Neurotol"},{"issue":"5","key":"7374_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/019459988509300501","volume":"93","author":"BW Pearson","year":"1985","unstructured":"Pearson BW, Brackmann DE (1985) Committee on hearing and equilibrium guidelines for reporting treatment results in Meniere\u2019s disease. Otolaryngol Head Neck Surg 93(5):579\u2013581","journal-title":"Otolaryngol Head Neck Surg"},{"key":"7374_CR23","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/lary.28445","volume":"130","author":"AW Gibson","year":"2019","unstructured":"Gibson AW, Moon IJ, Golub JS, Rubinstein JT (2019) A comparison of endolymphatic shunt surgery and intratympanic gentamicin for meniere\u2019s disease. Laryngoscope 130:2455","journal-title":"Laryngoscope"},{"key":"7374_CR24","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1007\/s00415-020-10011-5","volume":"268","author":"M Jiang","year":"2020","unstructured":"Jiang M, Zhang Z, Zhao C (2020) What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere\u2019s disease compared with steroids? A meta-analysis. J Neurol 268:3717","journal-title":"J Neurol"},{"issue":"4","key":"7374_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s101620010053","volume":"3","author":"JP Carey","year":"2002","unstructured":"Carey JP, Minor LB, Peng GC, Della Santina CC, Cremer PD, Haslwanter T (2002) Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for Meniere\u2019s disease. J Assoc Res Otolaryngol 3(4):430\u2013443","journal-title":"J Assoc Res Otolaryngol"},{"issue":"8","key":"7374_CR26","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1097\/00005537-200008000-00014","volume":"110","author":"DM Kaplan","year":"2000","unstructured":"Kaplan DM, Nedzelski JM, Chen JM, Shipp DB (2000) Intratympanic gentamicin for the treatment of unilateral Meniere\u2019s disease. Laryngoscope 110(8):1298\u20131305","journal-title":"Laryngoscope"},{"issue":"3","key":"7374_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/00016489850183359","volume":"118","author":"S Kaasinen","year":"1998","unstructured":"Kaasinen S, Pyykko I, Ishizaki H, Aalto H (1998) Intratympanic gentamicin in Meniere\u2019s disease. Acta Otolaryngol 118(3):294\u2013298","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"7374_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bbrc.2009.10.044","volume":"390","author":"H Kokotas","year":"2009","unstructured":"Kokotas H, Grigoriadou M, Korres GS, Ferekidou E, Papadopoulou E, Neou P et al (2009) The A1555G mitochondrial DNA mutation in Greek patients with non-syndromic, sensorineural hearing loss. Biochem Biophys Res Commun 390(3):755\u2013757","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"7374_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.amjoto.2019.06.008","volume":"40","author":"K Ozturk","year":"2019","unstructured":"Ozturk K, Ata N (2019) Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere\u2019s disease. Am J Otolaryngol 40(5):711\u2013714","journal-title":"Am J Otolaryngol"},{"key":"7374_CR30","doi-asserted-by":"publisher","first-page":"e1622","DOI":"10.6061\/clinics\/2020\/e1622","volume":"75","author":"Y Geng","year":"2020","unstructured":"Geng Y, Cao W, Xu H, Wu F, Feng T (2020) Effects of an intratympanic injection of dexamethasone combined with gentamicin on the expression level of serum P0 protein antibodies in patients with Meniere\u2019s disease. Clinics (Sao Paulo) 75:e1622","journal-title":"Clinics (Sao Paulo)"},{"issue":"6","key":"7374_CR31","doi-asserted-by":"publisher","first-page":"102289","DOI":"10.1016\/j.amjoto.2019.102289","volume":"40","author":"A Scarpa","year":"2019","unstructured":"Scarpa A, Ralli M, Cassandro C, Gioacchini FM, Alicandri-Ciufelli M, Viola P et al (2019) Low-dose intratympanic gentamicin administration for unilateral Meniere\u2019s disease using a method based on clinical symptomatology: preliminary results. Am J Otolaryngol 40(6):102289","journal-title":"Am J Otolaryngol"},{"issue":"8","key":"7374_CR32","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/lary.25156","volume":"125","author":"P Marques","year":"2015","unstructured":"Marques P, Manrique-Huarte R, Perez-Fernandez N (2015) Single intratympanic gentamicin injection in Meniere\u2019s disease: VOR change and prognostic usefulness. Laryngoscope 125(8):1915\u20131920","journal-title":"Laryngoscope"},{"issue":"1","key":"7374_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/MAO.0000000000001973","volume":"40","author":"E Martin-Sanz","year":"2019","unstructured":"Martin-Sanz E, Diaz JY, Esteban-Sanchez J, Sanz-Fernandez R, Perez-Fernandez N (2019) Delayed effect and gain restoration after intratympanic gentamicin for Meniere\u2019s disease. Otol Neurotol 40(1):79\u201387","journal-title":"Otol Neurotol"},{"issue":"4","key":"7374_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/00016489.2019.1708457","volume":"140","author":"JY Lee","year":"2020","unstructured":"Lee JY, Kim MB (2020) Change of VOR gain and pure-tone threshold after single low-dose intratympanic gentamicin injection in Meniere\u2019s disease. Acta Otolaryngol 140(4):314\u2013318","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"7374_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.amjoto.2010.07.021","volume":"32","author":"S Gode","year":"2011","unstructured":"Gode S, Celebisoy N, Akyuz A, Gulec F, Karapolat H, Bilgen C et al (2011) Single-shot, low-dose intratympanic gentamicin in Meniere disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome. Am J Otolaryngol 32(5):412\u2013416","journal-title":"Am J Otolaryngol"},{"issue":"6","key":"7374_CR36","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/coa.12449","volume":"40","author":"MI Syed","year":"2015","unstructured":"Syed MI, Ilan O, Nassar J, Rutka JA (2015) Intratympanic therapy in Meniere\u2019s syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol 40(6):682\u2013690","journal-title":"Clin Otolaryngol"},{"issue":"3","key":"7374_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/00016489.2020.1844289","volume":"141","author":"M Bertlich","year":"2021","unstructured":"Bertlich M, Ihler F, Spiegel JL, Canis M, Weiss BG (2021) Intratympanal administration of lidocaine in the management of Meniere\u2019s disease. Acta Otolaryngol 141(3):209\u2013215","journal-title":"Acta Otolaryngol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07374-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-022-07374-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07374-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T03:34:51Z","timestamp":1656732891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-022-07374-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7374"],"URL":"https:\/\/doi.org\/10.1007\/s00405-022-07374-y","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}